Literature DB >> 355575

Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates.

W R McCabe, B Kaijser, S Olling, M Uwaydah, L A Hanson.   

Abstract

Comparisons of O- and K-antigenic types and serum sensitivity were carried out with 149 strains of Escherichia coli isolated from adults with bacteremia and 46 strains from neonates with bacteremia. O-antigenic types O6, O4, O2, O16, O18, and O7 were observed most frequently, but their relative prevalence did not differ materially between adult and neonatal bacteremias. A greater proportion of strains from neonatal bacteremia contained K1 antigen and were autoagglutinable compared with strains from adult bacteremia, although K1 was the most frequent K antigen found in strains from adults. K-antigen-containing strains did not appear to be associated with enhanced severity of bacteremia, but nontypable strains, auto-agglutinable strains, and strains of O-antigenic types O4, O6, and O8 were associated with a greater frequency of shock and fatal outcome in adults. No differences could be detected between the serum sensitivities of E. coli isolated from adult bacteremia and those from neonatal bacteremia. K antigen did not affect serum sensitivity, but E. coli strains of O types O18, O2, O4, and O7 were more serum-resistant than other E. coli. Bacteremia caused by serum-sensitive E. coli was less often associated with shock and death than bacteremia caused by serum-resistant E. coli.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 355575     DOI: 10.1093/infdis/138.1.33

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  54 in total

1.  Inhibition of bactericidal activity of anticapsular antibody by nonspecific antibodies reactive with surface-exposed antigenic determinants on Actinobacillus pleuropneumoniae.

Authors:  F A Udeze; S Kadis
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

Review 2.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

3.  Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product.

Authors:  M Trautmann; T K Held; M Susa; M A Karajan; A Wulf; A S Cross; R Marre
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

4.  Release of endotoxic lipopolysaccharide by sensitive strains of Escherichia coli submitted to the bactericidal action of human serum.

Authors:  J Demonty; J De Graeve
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

5.  Recombinant human bactericidal/permeability-increasing protein (rBPI23) is a universal lipopolysaccharide-binding ligand.

Authors:  B J Appelmelk; Y Q An; B G Thijs; D M MacLaren; J de Graaff
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Zoonotic potential of Escherichia coli isolates from retail chicken meat products and eggs.

Authors:  Natalie M Mitchell; James R Johnson; Brian Johnston; Roy Curtiss; Melha Mellata
Journal:  Appl Environ Microbiol       Date:  2014-12-05       Impact factor: 4.792

7.  Serum response of Escherichia coli strains causing dyspepsia and urinary tract infection: relation to alpha-hemolysin production and O type.

Authors:  L Siegfried; M Kmetová; V Janigová; M Sasinka; V Takácová
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

8.  Thermoregulation-dependent expression of Yersinia enterocolitica protein 1 imparts serum resistance to Escherichia coli K-12.

Authors:  R J Martinez
Journal:  J Bacteriol       Date:  1989-07       Impact factor: 3.490

9.  Comparison of two molecular methods for tracing nosocomial transmission of Escherichia coli K1 in a neonatal unit.

Authors:  J I Alos; T Lambert; P Courvalin
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

10.  Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.

Authors:  H Frasa; B Benaissa-Trouw; L Tavares; K van Kessel; M Poppelier; K Kraaijeveld; J Verhoef
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.